TY - JOUR
T1 - Opioid-prescribing considerations in patients with cancer and substance misuse or substance use disorder
T2 - A scoping review protocol
AU - Jones, Katie Fitzgerald
AU - Malinowski, Jennifer
AU - Paice, Judith
AU - Childers, Julie
AU - Bulls, Hailey W.
AU - Morrison, Jeni
AU - Ho, J. Janet
AU - Alsbrook, Karen
AU - Nugent, Shannon
AU - Broglio, Kathleen
AU - Nickels, Katrina
AU - Holbein, Monika
AU - Parajuli, Jyotsana
AU - Merlin, Jessica S.
N1 - Publisher Copyright:
© 2023 Authors. All rights reserved.
PY - 2023/4/12
Y1 - 2023/4/12
N2 - Objective: This scoping review aims to describe factors in the existing literature that may inform opioid-prescribing decisions for patients with a past or present history of cancer and past or present substance misuse or substance use disorder. Introduction: Opioids and opioid-related decisions are critical components of cancer care. Most individuals with cancer will experience pain during cancer care, and over half of patients will receive an opioid prescription. Opioid-prescribing decisions require weighing the benefits and harms. The presence of substance misuse or substance use disorder may elevate the risk of opioid-related harms, but there is a lack of consensus on managing patients at this intersection. Inclusion criteria: This review will consider studies that include adult patients with a past or present history of cancer who also have pain and current or historical substance misuse or substance use disorder. The pain may be cancer-related or non-cancer-related. Studies of patients with all types of cancer will be eligible for inclusion, with the exception of non-melanoma skin cancers. Eligible studies will explore factors that inform opioid-prescribing decisions in this patient population. Methods: The review will be conducted according to JBI methodology for scoping reviews. Studies written in English since database inception will be included. The databases to be searched include MEDLINE (Ovid), CINAHL (EBSCO), Embase, APA PsycINFO, and Google Scholar. Eligible studies will undergo data extraction by 2 independent reviewers using a data extraction tool created by the authors. A narrative summary will describe study characteristics, population details, and strategies used to determine appropriate pain management in the patient population.
AB - Objective: This scoping review aims to describe factors in the existing literature that may inform opioid-prescribing decisions for patients with a past or present history of cancer and past or present substance misuse or substance use disorder. Introduction: Opioids and opioid-related decisions are critical components of cancer care. Most individuals with cancer will experience pain during cancer care, and over half of patients will receive an opioid prescription. Opioid-prescribing decisions require weighing the benefits and harms. The presence of substance misuse or substance use disorder may elevate the risk of opioid-related harms, but there is a lack of consensus on managing patients at this intersection. Inclusion criteria: This review will consider studies that include adult patients with a past or present history of cancer who also have pain and current or historical substance misuse or substance use disorder. The pain may be cancer-related or non-cancer-related. Studies of patients with all types of cancer will be eligible for inclusion, with the exception of non-melanoma skin cancers. Eligible studies will explore factors that inform opioid-prescribing decisions in this patient population. Methods: The review will be conducted according to JBI methodology for scoping reviews. Studies written in English since database inception will be included. The databases to be searched include MEDLINE (Ovid), CINAHL (EBSCO), Embase, APA PsycINFO, and Google Scholar. Eligible studies will undergo data extraction by 2 independent reviewers using a data extraction tool created by the authors. A narrative summary will describe study characteristics, population details, and strategies used to determine appropriate pain management in the patient population.
UR - http://www.scopus.com/inward/record.url?scp=85149678057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149678057&partnerID=8YFLogxK
U2 - 10.11124/JBIES-22-00007
DO - 10.11124/JBIES-22-00007
M3 - Review article
C2 - 36404752
AN - SCOPUS:85149678057
SN - 2689-8381
VL - 21
SP - 812
EP - 825
JO - JBI evidence synthesis
JF - JBI evidence synthesis
IS - 4
ER -